Founded in 1993 under its original company name; Cardiotech International, Inc., Nordicus Partners Corp. epitomizes a dynamic collaboration of Nordic and U.S. expertise. Our vision is clear: to leverage Nordic innovation and U.S. operational know-how, to create a unique advantage in identifying, scaling and exiting high-potential life sciences companies.

We advise and invest in Nordic and U.S. life sciences companies operating in high-growth markets with unmet medical needs. Our dedicated team, a blend of American and Nordic professionals, leverages this diversity in approach and perspective to drive success for both our company and the businesses we support.

Nordicus Partners Corp. is headquartered in the U.S. and publicly listed on the OTCQB Market under the ticker symbol “NORD”. The company’s management company is the Denmark-based company, Managementselskabet af 12.08.2020 A/S. With the management company being a wholly owned subsidiary, this strategic structure ensures that none of the investments made by our shareholders are allocated to cover management fees, thus maximizing the value of their investments.